MORF4L1 suppresses cell proliferation, migration and invasion by increasing p21 and E‑cadherin expression in nasopharyngeal carcinoma-Reference-Cited by-同舟云学术

MORF4L1 suppresses cell proliferation, migration and invasion by increasing p21 and E‑cadherin expression in nasopharyngeal carcinoma

Published:2018-10-16 Issue: Volume: Page:
ISSN:1792-1074
Container-title:Oncology Letters
language:
Short-container-title:Oncol Lett

Author:

Sang Yi¹,Zhang Ruhua²,Sun Longhua³,Chen Kaddie⁴,Li Si‑Wei⁵,Xiong Longxin¹,Peng Yongjian²,Zeng Lei⁶,Huang Guofu¹

Affiliation:

1. Nanchang Key Laboratory of Cancer Pathogenesis and Translational Research, Center Laboratory, The Third Affiliated Hospital, Nanchang University, Nanchang, Jiangxi 330008, P.R. China

2. State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat‑sen University Cancer Center, Guangzhou, Guangdong 510060, P.R. China

3. Respiratory Department, Nanchang Hospital of Integrative Traditional Chinese and Western Medicine, Jiangxi University of Traditional Chinese Medicine, Nanchang, Jiangxi 330008, P.R. China

4. College of Arts and Sciences, Cornell University, Ithaca, NY 14850, USA

5. Department of Radiation Oncology, The Affiliated Hospital of Guilin Medical University, Guilin, Guangxi 541000, P.R. China

6. Department of Radiation Oncology, Jiangxi Cancer Hospital, Nanchang, Jiangxi 330029, P.R. China

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Structural and functional insights into the epigenetic regulator MRG15;Acta Pharmacologica Sinica;2024-01-08

2. Insights into the molecular roles of FOXR2 in the pathology of primary pediatric brain tumors;Critical Reviews in Oncology/Hematology;2023-12

3. Identification of a chromatin regulator signature in prognosis and immune infiltration in breast cancer;2022-10-03

4. PRR11 unveiled as a top candidate biomarker within the RBM3 ‐regulated transcriptome in pancreatic cancer;The Journal of Pathology: Clinical Research;2021-08-11

5. In-depth proteomic analysis of proteasome inhibitors bortezomib, carfilzomib and MG132 reveals that mortality factor 4-like 1 (MORF4L1) protein ubiquitylation is negatively impacted;Journal of Proteomics;2021-06